So far, the roadmap Editor Paul McWilliams laid out for 2013 has been extremely accurate with rebounds and rallies in key segments of the tech sector. His new State of Tech report covers 71 technology stocks and dives deep into a number of exciting, emerging tech trends, well ahead of the Wall Street curve. Trial subscribers will receive the 167-page report, which includes 35 detailed tables and graphs, for free, no strings attached. This report is a must read for investors and analysts focusing on technology in 2013.

Already in 2013, McWilliams suggested buying several stocks ahead of quarterly earnings reports including Cree (up 57% year to date), Micron (up 48% year to date), Marvell (up 43% year to date), PMC Sierra (up 28% year to date) and SanDisk (up 25% year to date). Stocks he suggested avoiding/selling include Fusion-io (down 32% year to date) and Netlist (down 11% year to date). McWilliams' new State of Tech report outlines which stocks investors will want to own and which they should avoid as the market hits new all-time highs.

To get ahead of the Wall Street curve and receive Next Inning's in depth earnings previews for free, as well as McWilliams' upcoming Q1 2013 State or Tech report, you are invited to take a free, 21-day, no obligation trial with Next Inning. For full details on this offer, please visit the following link:

-- Cree: In 2012 when Cree was trudging through the low to mid-$20s, McWilliams encouraged Next Inning readers to build a position in the stock with his forecast that Cree would in fact grow profit margins in spite of dismal Wall Street forecasts. With Cree now trading above $50, does McWilliams think the investment has played out or is there reason to continue holding? What does McWilliams see in store for Cree going forward?

-- Intel: With market pundits finally promoting positive views of Intel that McWilliams was discussing a year or two ago, are Intel shares poised to ride a wave of new enthusiasm higher? Is Intel now well-positioned to be a leader in emerging mobile computing markets? What is McWilliams' short-term outlook for Intel? What does he expect from Intel as we move through the second half of 2013 and on into 2014?

-- Linear Technology: Just one day before Linear Tech hit its 52-week low in mid-2012, McWilliams "strongly" recommended buying the stock at its then current price of $28.75. McWilliams rarely makes "strong" suggestions like this so why did he make an exception in this case? Has he changed his opinion now that Linear Tech has reached his price objective or are there now reasons to raise the target?

-- Qualcomm: Does McWilliams expect Qualcomm to continue to dominate the high-end smartphone market in 2013? Can Qualcomm also overcome competition at the low end of the market? Might a resurgent Blackberry and Nokia provide a big boost for Qualcomm this year? What new competitive dynamics does McWilliams see developing for Qualcomm this year?

-- SanDisk: In July, when SanDisk was trading at $36.48, McWilliams told investors that SanDisk was deeply undervalued. With shares now 52% higher, does McWilliams expect further gains for SanDisk investors? Could SanDisk shares move above $70 in the near term? Do current dynamics in the memory market favor SanDisk?

Founded in September 2002, Next Inning's model portfolio has returned 238% since its inception versus 72% for the S&P 500.

About Next Inning:

Next Inning is a subscription-based investment newsletter that provides regular coverage on more than 150 technology and semiconductor stocks. Subscribers receive intra-day analysis, commentary and recommendations, as well as access to monthly semiconductor sales analysis, regular Special Reports, and the Next Inning model portfolio. Editor Paul McWilliams is a 30+ year semiconductor industry veteran.

NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926. Interested parties may visit adviserinfo.sec.gov for additional information. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.